EC Number | Cloned (Comment) | Organism |
---|---|---|
3.5.2.6 | expressed in Escherichia coli strain HB101 | Serratia marcescens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.2.6 | clavulanate | 62.2-92.1% of activity is inhibited after preincubation with 0.1 mM clavulanate | Serratia marcescens | |
3.5.2.6 | EDTA | 0.1 mM EDTA inhibits only 4.8-26.8% of the activity of the TEM-type beta-lactamase | Serratia marcescens | |
3.5.2.6 | additional information | shows high-level resistance to expanded-spectrum cephalosporins and beta-lactam clavulanate combinations | Serratia marcescens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.2.6 | Serratia marcescens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.2.6 | nitrocefin + H2O | - |
Serratia marcescens | (2R)-2-{(R)-carboxy[2-(thiophen-2-yl)acetamido]methyl}-5-[(E)-2-(2,4-dinitrophenyl)ethenyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.2.6 | TEM-type beta-lactamase | - |
Serratia marcescens |